[ 5 2 ]
M EX ICA N SC I E NC E AGA I N ST C OV I D -19: SI LV E R BU L L E T By: Dolores Garnica Essayist and journalist. She has worked as a promoter, manager and communicator. She is a columnist for ITESO’s Magis magazine and a regular contributor to Luvina, a magazine of the University of Guadalajara. His first book of essays, “Un gris, casi verde ”, by Editorial Paraíso Perdido, was presented in 2017.
Science at the service of the community. In the city of Guadalajara, Mexico, a group of scientists works to help in a clinical trial. The idea, most importantly, is to develop effective treatments against COVID-19, and maybe, a vaccine. They have already obtained the difficult Mexican certification to carry out the study. This is the first protocol against the coronavirus made by the private initiative in Mexico as CidVID explains in the press release.
We are sure that the science of COVID-19 will be one of the fundamental topics in scientific meetings and journals. Like the CLiR group in the coming months, and years. The scientists are part of the biometric research company CidVID. Based in Mexico but with a global presence. Starting June this year, a team of scientists, doctors, and patient volunteers will make Silver Bullet a reality. As they named their study, a title with several readings, all positive.
